Douglas A Treco - Net Worth and Insider Trading
Douglas A Treco Net Worth
The estimated net worth of Douglas A Treco is at least $91,753 dollars as of 2024-04-27. Douglas A Treco is the CEO of Inozyme Pharma Inc and owns about 20,665 shares of Inozyme Pharma Inc (INZY) stock worth over $91,753. Details can be seen in Douglas A Treco's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas A Treco has not made any transactions after 2024-04-02 and currently still holds the listed stock(s).
Transaction Summary of Douglas A Treco
Douglas A Treco Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas A Treco owns 3 companies in total, including Inozyme Pharma Inc (INZY) , CRISPR Therapeutics AG (CRSP) , and Ra Pharmaceuticals Inc (RARX) .
Click here to see the complete history of Douglas A Treco’s form 4 insider trades.
Insider Ownership Summary of Douglas A Treco
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2024-04-02 | director |
| CRSP | CRISPR Therapeutics AG | 2020-06-11 | director |
| RARX | Ra Pharmaceuticals Inc | 2020-04-02 | director & President and CEO |
Douglas A Treco Latest Holdings Summary
Douglas A Treco currently owns a total of 1 stock. Douglas A Treco owns 20,665 shares of Inozyme Pharma Inc (INZY) as of April 2, 2024, with a value of $91,753.
Latest Holdings of Douglas A Treco
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2024-04-02 | 20,665 | 4.44 | 91,753 |
Holding Weightings of Douglas A Treco
Douglas A Treco Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas A Treco has made a total of 1 transactions in Inozyme Pharma Inc (INZY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Inozyme Pharma Inc is the sale of 7,523 shares on April 2, 2024, which brought Douglas A Treco around $52,210.
Insider Trading History of Douglas A Treco
- 1
Douglas A Treco Trading Performance
Douglas A Treco Ownership Network
Ownership Network List of Douglas A Treco
Ownership Network Relation of Douglas A Treco
Douglas A Treco Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Douglas A Treco is the director of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Douglas A Treco made 1 insider transaction in Inozyme Pharma Inc (INZY) with a net sale of 7,523. Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. ,
In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Douglas A Treco Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas A Treco. You might contact Douglas A Treco via mailing address: 87 Cambridgepark Drive, C/o Ra Pharmaceuticals, Inc., Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
